Protara Therapeutics stock price
NASDAQ:TARA · Nasdaq · Healthcare · sector #16Protara Therapeutics's chart data is dated 2026-10-21. Recorded technical signals: RSI rebound, MACD bullish cross, Mean reversion. The display ticker is TARA.
Protara Therapeutics last closed at $2.50 (-2.34%) on 2026-10-21. Signals today: RSI rebound, MACD bullish cross, Mean reversion. Listed on Nasdaq. Trailing 12 months PER is -2.2×. Its overall grade ranks 551 of 726 stocks in Healthcare.
About this company
Protara Therapeutics last closed at $2.50 (-2.34%) on 2026-10-21. Signals today: RSI rebound, MACD bullish cross, Mean reversion. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall C · 551/726
Valuation grade A-
Related stocks
- AstraZenecaCompetitor
- Bristol Myers SquibbCompetitor
- Merck & CoCompetitor
About Protara Therapeutics
- What technical signals does Protara Therapeutics (TARA) have?
- Protara Therapeutics current technical signals: RSI rebound, MACD bullish cross, Mean reversion.
- Is Protara Therapeutics a cup-and-handle pattern?
- No. Protara Therapeutics has no valid Cup signal right now.
- What published figures are available for Protara Therapeutics?
- Market cap: $129.08M. Trailing 12 months PER: -2.2×. Latest quarter PBR: 0.97×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Protara Therapeutics, or open the plan table on the main site.
Ask Q about Protara Therapeutics.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.